Acta Chir Orthop Traumatol Cech. 2023; 90(3):176-180 | DOI: 10.55095/achot2023/022

Effects of Tranexamic Acid on Perioperative Blood Loss and Wound Hematoma Development in Lumbar Spine Surgery: a Prospective Randomized StudyOriginal papers

P. STEJSKAL, ©. TRNKA*, L. HRABÁLEK, T. WANEK, J. JABLONSKÝ, V. NOVÁK
Neurochirurgická klinika Fakultní nemocnice Olomouc a Lékařské fakulty Univerzity Palackého v Olomouci

PURPOSE OF THE STUDY:
Tranexamic acid as a haemostatic agent is commonly used in multiple medical branches. Over the last decade, there has been a steep rise in the number of studies evaluating its effect, i.e. blood loss reduction in specific surgical procedures. The aim of our study was to evaluate the effect of tranexamic acid on reducing intraoperative blood loss, postoperative blood loss into the drain, total blood loss, transfusion requirements, and development of symptomatic wound hematoma in conventional single-level lumbar decompression and stabilization.

MATERIAL AND METHODS:
The study included patients who had undergone a traditional open lumbar spine surgery in the form of single-level decompression and stabilisation. The patients were randomized into two groups. The study group received a 15 mg/kg dose of tranexamic acid intravenously during the induction of anaesthesia and then again 6 hours later. No tranexamic acid was administered to the control group. In all patients, intraoperative blood loss, postoperative blood loss into the drain, and therefore also total blood loss, transfusion requirements and potential development of a symptomatic postoperative wound hematoma requiring surgical evacuation were recorded. The data of the two groups were compared.

RESULTS:
The cohort includes 162 patients, 81 in the study group and the same number in the control group. In the intraoperative blood loss assessment, no statistically significant difference between the two groups was observed; 430 (190-910) mL vs. 435 (200-900) mL. In case of post-operative drain blood loss, a statistically significantly lower volume was reported after the tranexamic acid administration; 405 (180-750) mL vs. 490 (210-820) mL. When evaluating the total blood loss, a statistically significant difference was also confirmed, namely in favour of the tranexamic acid; 860 (470-1410) mL vs. 910 (500-1420) mL. The reduction of total blood loss did not result in a difference in the number of administered transfusions; transfusions were given to 4 patients in each group. A postoperative wound hematoma requiring surgical evacuation developed in 1 patient in the group with the tranexamic acid and in 4 patients in the control group, but the difference was not statistically significant with respect to the insufficient group size. No patient in our study experienced complications associated with tranexamic acid application.

DISCUSSION:
The beneficial effect of tranexamic acid on reducing blood loss in lumbar spine surgeries has already been confirmed by numerous meta-analyses. The question remains in what types of procedures, at what dose and route of administration its effect is significant. To date, most of the studies have explored its effect in multi-level decompressions and stabilizations. Raksakietisak et al., for instance, report significant reduction in total blood loss from 900 (160, 4150) mL to 600 (200, 4750) mL following an intravenous injection of 2 bolus doses of 15 mg/kg tranexamic acid. In less extensive spinal surgeries, the effect of tranexamic acid may not be that distinct. In our study of single-level decompressions and stabilizations, no reduction in the actual intraoperative bleeding was confirmed at the given dosage. Its effect was seen only in the postoperative period in a significant reduction of blood loss into the drain, thus also in the total blood loss, although the difference between 910 (500, 1420) mL and 860 (470, 1410) mL was not that significant.

CONCLUSIONS:
By intravenous application of tranexamic acid in 2 bolus doses in single-level decompression and stabilization of the lumbar spine a statistically significant reduction in postoperative blood loss into the drain and also total blood loss was confirmed. The reduction in the actual intraoperative blood loss was not statistically significant. No difference was observed in the number of administered transfusions. Following the tranexamic acid administration, a lower number of postoperative symptomatic wound hematomas was recorded, but the difference was not statistically significant.

Keywords: tranexamic acid, spinal surgeries, blood loss, postoperative hematoma

Published: June 22, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
STEJSKAL P, TRNKA ©, HRABÁLEK L, WANEK T, JABLONSKÝ J, NOVÁK V. Effects of Tranexamic Acid on Perioperative Blood Loss and Wound Hematoma Development in Lumbar Spine Surgery: a Prospective Randomized Study. Acta Chir Orthop Traumatol Cech. 2023;90(3):176-180. doi: 10.55095/achot2023/022. PubMed PMID: 37395424.
Download citation

References

  1. Arun-Kumar V, Naresh-Babu J. Is there a role for preoperative local infiltration of tranexamic acid in elective spine surgery? A prospective randomized controlled trial analyzing the efficacy of intravenous, local infiltration, and topical administration of tranexamic acid. Global Spine J. 2021;11:2127. Go to original source...
  2. Bao X, Lu H, Gao Z, Wu Z, Chen Y, Chen Y, Cheng Q. Meta-analysis of the efficacy and safety of tranexamic acid in spinal surgery. Comput Math Methods Med. 2022;2022:9406497. Go to original source...
  3. Farrokhi MR, Kazemi AP, Eftekharian HR, Akbari K. Efficacy of prophylactic low dose of tranexamic acid in spinal fixation surgery: a randomized clinical trial. J Neurosurg Anesthesiol. 2011;23:290-296. Go to original source... Go to PubMed...
  4. Hui S, Xu D, Ren Z, Chen X, Sheng L, Zhuang Q, Li S. Can tranexamic acid conserve blood and save operative time in spinal surgeries? A meta-analysis. Spine J. 2017;18:1325-1337. Go to original source...
  5. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:3054. Go to original source...
  6. Liu ZG, Yang F, Zhu YH, Liu GC, Zhu QS, Zhang BY. Is tranexamic acid beneficial in open spine surgery ? and its effects vary by dosage, age, sites, and locations: a meta-analysis of randomized controlled trials. World Neurosurg. 2022;166:141-152. Go to original source... Go to PubMed...
  7. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med. 2008;36:2667-2674. Go to original source...
  8. Ng W, Jerath A, W±sowicz M. Tranexamic acid: a clinical review. Anaesthesiol Intensive Ther. 2015;47:339-350. Go to original source... Go to PubMed...
  9. Perel P, Ker K, Morales Uribe CH, Roberts I. Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database Syst Rev. 2013;2013:CD010245. Go to original source...
  10. Peters A, Verma K, Slobodyanyuk K, Cheriyan T, Hoelscher C, Schwab F, Lonner B, Huncke T, Lafage V, Errico T. Antifibrinolytics reduce blood loss in adult spinal deformity surgery: a prospective, randomized controlled trial. Spine (Phila Pa 1976) 2015;40:443-449. Go to original source...
  11. Qi MT, Wang SY, Wang LT, Chen XW, Zhan WH, Zhu XF, Wang H. [Effects of oral and intravenous tranexamic acid on perioperative blood loss after lumbar spinal canal decompression and fusion]. Zhongguo Gu Shang. 2022;35:736-739. Go to PubMed...
  12. Rahmani R, Singleton A, Fulton Z, Pederson JM, Andreshak T. Tranexamic acid dosing strategies and blood loss reduction in multilevel spine surgery: a systematic review and network meta-analysis: tranexamic acid for multilevel spine surgery. N Am Spine Soc J. 2021;8:100086. Go to original source... Go to PubMed...
  13. Raksakietisak M, Sathitkarnmanee B, Srisaen P, Duangrat T, Chinachoti T, Rushatamukayanunt P, Sakulpacharoen N. Two doses of tranexamic acid reduce blood transfusion in complex spine surgery: a prospective randomized study. Spine (Phila Pa 1976). 2015;40:1257-1263. Go to original source...
  14. Raman T, Varlotta C, Vasquez-Montes D, Buckland AJ, Errico TJ. The use of tranexamic acid in adult spinal deformity: is there an optimal dosing strategy? Spine J. 2019;19:1690-1697. Go to original source...
  15. Tengborn L, Blombäck M, Berntorp E. Tranexamic acid - an old drug still going strong and making a revival. Thromb Res. 2015;135:231-242. Go to original source...
  16. Xiong Z, Wu K, Zhang J, Leng D, Yu Z, Zhang C, Yi P. Different dose regimens of intravenous tranexamic acid in adolescent spinal deformity surgery: a systematic review and meta-analysis. BioMed Res Int. 2020;2020:1-16. Go to original source...
  17. Yuan L, Zeng Y, Chen ZQ, Zhang XL, Mai S, Song P, Tao LY. Efficacy and safety of antifibrinolytic agents in spinal surgery: a network meta-analysis. Chin Med J (Engl). 2019;132:577-588. Go to original source... Go to PubMed...
  18. Zhao Y, Xi C, Xu W, Yan J. Role of tranexamic acid in blood loss control and blood transfusion management of patients undergoing multilevel spine surgery: a meta-analysis. Medicine (Baltimore). 2021;100:24678. Go to original source...